Johan Vansteenkiste

Researcher Next ID · RN-007705

Researcher · Medicine

Leuven, Belgium

Not currently recruitingFunding unknown

Research interests

Medicine

Lung Cancer Treatments and Mutations

Lung Cancer Research Studies

Cancer Immunotherapy and Biomarkers

Lung Cancer Diagnosis and Treatment

Colorectal Cancer Treatments and Studies

Overall Survival with Osimertinib in Untreated, EGFR -Mutated Advanced NSCLC
New England Journal of Medicine · 2019 · https://doi.org/10.1056/nejmoa1913662
Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC
New England Journal of Medicine · 2018 · https://doi.org/10.1056/nejmoa1809697
Osimertinib in Untreated EGFR -Mutated Advanced Non–Small-Cell Lung Cancer
New England Journal of Medicine · 2017 · https://doi.org/10.1056/nejmoa1713137
Phase III Study Comparing Cisplatin Plus Gemcitabine With Cisplatin Plus Pemetrexed in Chemotherapy-Naive Patients With Advanced-Stage Non–Small-Cell Lung Cancer
Journal of Clinical Oncology · 2008 · https://doi.org/10.1200/jco.2007.15.0375
Multi-Institutional Randomized Phase II Trial of Gefitinib for Previously Treated Patients With Advanced Non–Small-Cell Lung Cancer
Journal of Clinical Oncology · 2003 · https://doi.org/10.1200/jco.2003.10.038

No projects listed.